Oric Pharmaceuticals, Inc. ORIC Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s other commercial liabilities?
- Oric Pharmaceuticals, Inc. (ORIC) reported other commercial liabilities of $14.88M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s other commercial liabilities changed year-over-year?
- Oric Pharmaceuticals, Inc.'s other commercial liabilities increased by 19.4% year-over-year, from $12.46M to $14.88M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s other commercial liabilities has grown at a 15.0% compound annual growth rate (CAGR), from $8.25M to $16.59M.